GlassScriptPhysician profile
Callista Morris
NPI 1962790683
$5,427.12
in general payments reported to CMS, 2019-2025
8 companies · $3,201 in 2025
The $3,201 reported for 2025 was more than what 76% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2021: $134 · 2022: $25.87 · 2023: $498 · 2024: $776 · 2025: $3,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,914 · Food and Beverage: $1,413 · Education: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,914.48 |
| Food and Beverage | $1,412.85 |
| Education | $1,147.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,954.95 | 2019-2025 | Arthrex |
| Stryker Corporation | $1,739.08 | 2019-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Novus Surgical Consultants | $487.92 | 2023-2025 | |
| Depuy Synthes Sales INC. | $78.17 | 2025 | Unium |
| Fx Shoulder Solutions, INC | $69.27 | 2021-2022 | |
| Smith+Nephew, INC. | $41.09 | 2019 | |
| Vericel Corporation | $31.32 | 2024 | Maci |
| Linvatec Corporation | $25.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callista Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.